发明授权
- 专利标题: Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems
- 专利标题(中): 含有功能活性融合肽作为药物递送系统的合成膜囊泡
-
申请号: US930593申请日: 1992-11-02
-
公开(公告)号: US6040167A公开(公告)日: 2000-03-21
- 发明人: Reinhard Gluck , Peter Klein , Peter Herrmann , Ernst Rudolf Walti
- 申请人: Reinhard Gluck , Peter Klein , Peter Herrmann , Ernst Rudolf Walti
- 申请人地址: LIX
- 专利权人: Nika Health Products Limited
- 当前专利权人: Nika Health Products Limited
- 当前专利权人地址: LIX
- 优先权: EPX91101414 19910202
- 主分类号: A61K9/127
- IPC分类号: A61K9/127 ; A61K31/16 ; A61K31/17 ; A61K31/415 ; A61K31/505 ; A61K31/675 ; A61K31/70 ; A61K39/395 ; A61K47/24 ; A61K47/48 ; A61P31/18 ; A61P35/00 ; C12N7/00 ; C07K14/11
摘要:
The phospholipid bilayer contains at least one pharmaceutically active drug and comprises cell-specific markers on the membrane which have at least 90% biological activity when measured according to Luescher & Glueck, Antiviral Research 14, 39-50. In the membrane, the cholesterol content is preferably less than 2% by weight, the detergent content preferably less than 1 ppb. The vesicle diameter preferably is about 80 nm. the phospholipid in the membrane may comprise 70 to 95% by weight of phosphatidylcholine and preferably 10 to 20% by weight of phosphatidylethanolamine; preferably 6-8% by weight of a crosslinker, preferably of a sulfosuccinimidyl derivate, and at least one cell-specific fusion peptide are linked to the membrane. The vesicles are used for the preparation of pharmaceuticals against AIDS and carcinomas.
公开/授权文献
- US6082835A Differential braking control in road vehicles 公开/授权日:2000-07-04
信息查询